相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models
Eleanor J. Guest et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Prediction of Fluoroquinolone-Induced Elevation in Serum Creatinine Levels: A Case of Drug-Endogenous Substance Interaction Involving the Inhibition of Renal Secretion
Y. Imamura et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study
K. Maeda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
Rune Amundsen et al.
DRUG METABOLISM AND DISPOSITION (2010)
Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
Takao Watanabe et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Long-Lasting Inhibition of the Transporter-Mediated Hepatic Uptake of Sulfobromophthalein by Cyclosporin A in Rats
Yoshihisa Shitara et al.
DRUG METABOLISM AND DISPOSITION (2009)
Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein
T. Tachibana et al.
XENOBIOTICA (2009)
Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4
Masakazu Hirouchi et al.
DRUG METABOLISM AND DISPOSITION (2009)
Multiple inhibition mechanisms and prediction of drug-drug interactions: Status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions
Laura K. Hinton et al.
PHARMACEUTICAL RESEARCH (2008)
Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans
Soichiro Matsushima et al.
DRUG METABOLISM AND DISPOSITION (2008)
Multiple human Isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-Receptor
Akihiro Yamada et al.
DRUG METABOLISM AND DISPOSITION (2007)
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3
Johannes Noe et al.
DRUG METABOLISM AND DISPOSITION (2007)
Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension
Milica Bajcetic et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans
Naoki Ishiguro et al.
DRUG METABOLISM AND DISPOSITION (2006)
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
Masaru Hirano et al.
DRUG METABOLISM AND DISPOSITION (2006)
Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2
M Hirouchi et al.
PHARMACEUTICAL RESEARCH (2004)
Database analyses for the prediction of in vivo drug-drug interactions from in vitro data
K Ito et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
M Hirano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects
H Sabia et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Characterization of uremic toxin transport by organic anion transporters in the kidney
T Deguchi et al.
KIDNEY INTERNATIONAL (2004)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol
T Satoh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
分享论文
